Press Releases

Press Releases

February 28, 2022
CytomX Therapeutics to Present at Cowen 42nd Annual Healthcare Conference
SOUTH SAN FRANCISCO, Calif. , Feb. 28, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics , Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated oncology therapeutics, today announced that Sean McCarthy , D.Phil ., chief executive officer and chairman, will participate in a virtual panel
Additional Formats
February 16, 2022
CytomX Therapeutics Announces New Employment Inducement Grants
SOUTH SAN FRANCISCO, Calif. , Feb. 16, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated oncology therapeutics, today announced that on February 16, 2022 , the Company granted nine new employees options to purchase a total of 189,400
Additional Formats
January 20, 2022
CytomX Therapeutics Announces New Employment Inducement Grants
SOUTH SAN FRANCISCO, Calif. , Jan. 20, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated therapeutics, today announced that on January 18, 2022 , the Company granted four new employees options to purchase a total of 127,000 shares of
Additional Formats
Displaying 21 - 28 of 28